UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 76 filers reported holding UROGEN PHARMA LTD in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $281,000 | -48.1% | 14,450 | -51.9% | 0.04% | -52.0% |
| Q4 2020 | $541,000 | +39.8% | 30,020 | +102.4% | 0.08% | -17.6% |
| Q2 2020 | $387,000 | +50.0% | 14,831 | +2.4% | 0.09% | +12.3% |
| Q1 2020 | $258,000 | -54.7% | 14,481 | -15.1% | 0.08% | -35.2% |
| Q4 2019 | $569,000 | -12.9% | 17,055 | -37.4% | 0.12% | -21.9% |
| Q3 2019 | $653,000 | -30.0% | 27,230 | +4.9% | 0.16% | -30.1% |
| Q2 2019 | $933,000 | +4.7% | 25,970 | +7.6% | 0.23% | +7.0% |
| Q1 2019 | $891,000 | +303.2% | 24,125 | +416.6% | 0.21% | +296.3% |
| Q3 2018 | $221,000 | -93.4% | 4,670 | -93.0% | 0.05% | -94.1% |
| Q2 2018 | $3,340,000 | +28.5% | 67,125 | +28.3% | 0.91% | +35.6% |
| Q1 2018 | $2,599,000 | – | 52,300 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
| GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
| HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
| Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
| Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
| ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
| RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
| SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |